The Design of Organometallic Ruthenium Arene Anticancer Agents

ISSN： 0009-4293

Source： CHIMIA International Journal for Chemistry, Vol.61, Iss.11, 2007-11, pp. : 704-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ruthenium(II) Arene Compounds as Versatile Anticancer Agents

By Renfrew Anna

CHIMIA International Journal for Chemistry, Vol. 63, Iss. 4, 2009-04 ,pp. : 217-219

Swiss Chemical Society

Access to resources Recommend Favorite

Development of Organometallic Ruthenium(II) Anticancer (RAPTA) Drugs

By Ang Wee Han

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 4, 2007-04 ,pp. : 140-142

Swiss Chemical Society

Access to resources Recommend Favorite

Rational Design of Organo-Ruthenium Anticancer Compounds

By Gossens Christian Tavernelli Ivano Rothlisberger Ursula

CHIMIA International Journal for Chemistry, Vol. 59, Iss. 3, 2005-03 ,pp. : 81-84

Swiss Chemical Society

Access to resources Recommend Favorite

Histone‐Deacetylase‐Targeted Fluorescent Ruthenium(II) Polypyridyl Complexes as Potent Anticancer Agents

CHEMISTRY - A EUROPEAN JOURNAL, Vol. 19, Iss. 31, 2013-07 ,pp. : 10160-10169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ruthenium Anticancer Compounds: Challenges and Expectations

By Bratsos Ioannis Jedner Stephanie Gianferrara Teresa Alessio Enzo

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 11, 2007-11 ,pp. : 692-697

Swiss Chemical Society

Access to resources Recommend Favorite